1-(2,5-dimethylphenyl)sulfonyl-2-[1-phenyl-3-[4-(trifluoromethyl)phenyl]pyrazol-4-yl]benzimidazole
C31H23F3N4O2S — CID 155567725
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2,5-dimethylphenyl)sulfonyl-2-[1-phenyl-3-[4-(trifluoromethyl)phenyl]pyrazol-4-yl]benzimidazole
1-(2,5-dimethylphenyl)sulfonyl-2-[1-phenyl-3-[4-(trifluoromethyl)phenyl]pyrazol-4-yl]benzimidazole (PubChem CID 155567725) has the molecular formula C31H23F3N4O2S and a molecular weight of 572.61 g/mol. Its IUPAC name is 1-(2,5-dimethylphenyl)sulfonyl-2-[1-phenyl-3-[4-(trifluoromethyl)phenyl]pyrazol-4-yl]benzimidazole.
Molecular Properties
| Compound Name | 1-(2,5-dimethylphenyl)sulfonyl-2-[1-phenyl-3-[4-(trifluoromethyl)phenyl]pyrazol-4-yl]benzimidazole |
|---|---|
| PubChem CID | 155567725 |
| Molecular Formula | C31H23F3N4O2S |
| Molecular Weight | 572.61 g/mol |
| Exact Mass | 572.15 |
| IUPAC Name | 1-(2,5-dimethylphenyl)sulfonyl-2-[1-phenyl-3-[4-(trifluoromethyl)phenyl]pyrazol-4-yl]benzimidazole |
| SMILES | Cc1ccc(C)c(S(=O)(=O)n2c(-c3cn(-c4ccccc4)nc3-c3ccc(C(F)(F)F)cc3)nc3ccccc32)c1 |
| InChI | InChI=1S/C31H23F3N4O2S/c1-20-12-13-21(2)28(18-20)41(39,40)38-27-11-7-6-10-26(27)35-30(38)25-19-37(24-8-4-3-5-9-24)36-29(25)22-14-16-23(17-15-22)31(32,33)34/h3-19H,1-2H3 |
| InChIKey | MVJRKGVVBCIGAH-UHFFFAOYSA-N |
| XLogP | 7.43 |
| TPSA | 69.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 572.61 |
| LogP ≤ 5 | 7.43 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155567725 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.